SUPERNUS PHARMACEUTICALS, INC. Inventory
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Inventory of $107.03 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-03
- 2026-06-30: Inventory, Net $107.03M.
- 2026-03-31: Inventory, Net $110.77M.
- 2025-12-31: Inventory, Net $112.48M.
- 2025-09-30: Inventory, Net $107.10M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $107.03M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $110.77M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $112.48M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $107.10M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $44.02M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $49.42M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $54.29M 10-K · filed 2026-03-02 |
| 2024-09-30 | $63.98M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $68.16M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $75.08M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $77.41M 10-K · filed 2025-02-25 |
| 2023-09-30 | $83.48M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $90.56M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $91.15M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $91.54M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $83.17M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $84.86M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $88.80M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $85.96M 10-K · filed 2023-03-09 |
| 2021-09-30 | $60.16M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $58.39M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $50.23M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $48.33M 10-K · filed 2022-04-13 |
| 2020-09-30 | $42.47M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $35.34M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $24.42M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $26.63M 10-K · filed 2021-03-08 |
| 2019-09-30 | $25.50M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $26.02M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $26.52M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $25.66M 10-K · filed 2020-02-28 |
| 2018-09-30 | $23.28M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $20.68M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $19.07M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $16.30M 10-K · filed 2019-03-01 |
| 2017-09-30 | $14.95M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.62M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $19.17M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $16.80M 10-K · filed 2018-03-01 |
| 2016-09-30 | $17.45M 10-Q · filed 2017-01-20 |
| 2016-06-30 | $16.37M 10-Q/A · filed 2017-01-23 |
| 2016-03-31 | $13.04M 10-Q/A · filed 2017-01-20 |
| 2015-12-31 | $12.59M 10-K · filed 2017-03-16 |
| 2015-09-30 | $14.74M 10-Q/A · filed 2017-01-20 |
| 2015-06-30 | $13.59M 10-Q/A · filed 2017-01-23 |
| 2015-03-31 | $13.70M 10-Q/A · filed 2017-01-20 |
| 2014-12-31 | $13.44M 10-Q/A · filed 2017-01-20 |
| 2014-09-30 | $11.14M 10-Q/A · filed 2017-01-20 |
| 2014-06-30 | $10.10M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $7.96M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $7.15M 10-K · filed 2015-03-12 |
| 2013-09-30 | $5.19M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $4.32M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $3.11M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.15M 10-K · filed 2014-03-21 |
| 2012-09-30 | $26.00K 10-Q · filed 2012-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |